Skip to content.
About GPO   |   Newsroom/Media   |   Congressional Relations   |   Inspector General   |   Careers   |   Contact   |   askGPO   |   Help  
 

  FDsys > More Information
(Search string is required)
 

17-661 - Martin v. Bristol-Myers Company et al


Download Files

Metadata

Document in Context
17-661 - Martin v. Bristol-Myers Company et al
March 20, 2017
PDF | More
Judicial Referral for Purpose of Determining Relationship of Cases re 17-cv-661. Signed by Magistrate Judge Donna M. Ryu on March 20, 2017. (dmrlc2, COURT STAFF) (Filed on 3/20/2017)
June 23, 2017
PDF | More
STIPULATION AND ORDER re (10 in 3:17-cv-03098-JST) STIPULATION WITH [PROPOSED] ORDER to Continue Case Management Conference filed by McKesson Corporation, AstraZeneca Pharmaceuticals, L.P., Bristol-Myers Squibb Company, (10 in 3:17-cv-03180-JST) STIPULATION WITH PROPOSED ORDER to Continue Case Manangement Conference filed by McKesson Corporation, AstraZeneca Pharmaceuticals, L.P., Bristol-Myers Squibb Company, (9 in 3:17-cv-03019-JST) STIPULATION WITH PROPOSED ORDER to Continue Case Management Conference filed by McKesson Corporation, AstraZeneca Pharmaceuticals, L.P., Bristol-Myers Squibb Company, (62 in 3:16-cv-07152-JST) STIPULATION WITH PROPOSED ORDER to Continue Case Management Conference filed by AstraZeneca Pharmaceuticals LP, McKesson Corporation, Bristol-Myers Squibb Company. Case Management Statement due by 7/6/2017. Initial Case Management Conference set for 7/12/2017 at 10:00 PM in Courtroom 9, 19th Floor, San Francisco. Signed by Judge Jon S. Tigar on June 23, 2017. (wsn, COURT STAFF) (Filed on 6/23/2017)
September 28, 2017
PDF | More
STIPULATION AND ORDER re (90 in 3:16-cv-07152-JST) STIPULATION WITH PROPOSED ORDER to Continue Hearing of Plaintiff's Motion to Dismiss and to Continue Case Management Conference filed by AstraZeneca Pharmaceuticals LP, McKesson Corporation, Bristol-Myers Squibb Company, (47 in 3:17-cv-00661-JST) STIPULATION WITH PROPOSED ORDER to Continue Hearing of Plaintiff's Motion to Dismiss and to Continue Case Management Conference filed by AstraZeneca Pharmaceuticals LP, McKesson Corporation, Bristol-Myers Company. Signed by Judge Jon S. Tigar on September 28, 2017. (wsn, COURT STAFF) (Filed on 9/28/2017)
October 30, 2017
PDF | More
ROPOSED] ORDER to Continue Case Management Conference filed by AstraZeneca Pharmaceuticals LP, McKesson Corporation, Bristol-Myers Squibb Company. Case Management Statement due by 12/11/2017. Further Case Management Conference set for 12/20/2017 at 2:00 PM in Courtroom 9, 19th Floor, San Francisco. Signed by Judge Jon S. Tigar on October 30, 2017. (wsn, COURT STAFF) (Filed on 10/30/2017)STIPULATION AND ORDER re (53 in 3:17-cv-00661-JST) STIPULATION WITH [PROPOSED] ORDER to Continue Case Management Conference filed by AstraZeneca Pharmaceuticals LP, Bristol-Myers Company; (97 in 3:16-cv-07152-JST) STIPULATION WITH [P
February 1, 2018
PDF | More
rs Squibb Company. Case Management Statement due by 2/26/2018. Initial Case Management Conference set for 3/7/2018 at 2:00 PM in San Francisco, Courtroom 09, 19th Floor. Signed by Judge Jon S. Tigar on February 1, 2018. (wsn, COURT STAFF) (Filed on 2/1/2018)STIPULATION AND ORDER re (101 in 3:16-cv-07152-JST) STIPULATION WITH [PROPOSED] ORDER To Continue Case Management Conference Pursuant to N.D. Cal. Civ. L.R. 6-1 filed by AstraZeneca Pharmaceuticals LP, McKesson Corporation, Bristol-Mye
February 13, 2018
PDF | More
TRANSFER ORDER by the United States Judicial Panel on Multidistrict Litigation TRANSFERRING CASE to the United States District Court for the Eastern District of Kentucky, MDL No. 2809. (tnS) (Filed on 2/13/2018)